These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels. Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413 [TBL] [Abstract][Full Text] [Related]
3. [A case of xp11.2 translocation renal cell carcinoma]. Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884 [TBL] [Abstract][Full Text] [Related]
4. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma. Woo S; Kim SY; Lee MS; Moon KC; Kim SH; Cho JY; Kim SH AJR Am J Roentgenol; 2015 Mar; 204(3):542-9. PubMed ID: 25714283 [TBL] [Abstract][Full Text] [Related]
5. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. Wang W; Ding J; Li Y; Wang C; Zhou L; Zhu H; Peng W PLoS One; 2014; 9(6):e99990. PubMed ID: 24926688 [TBL] [Abstract][Full Text] [Related]
7. [Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings]. Zhu Q; Zhu W; Wu J; Fu J; Chen W; Wang Z Zhonghua Yi Xue Za Zhi; 2014 May; 94(19):1470-2. PubMed ID: 25143166 [TBL] [Abstract][Full Text] [Related]
8. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901 [TBL] [Abstract][Full Text] [Related]
9. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790 [TBL] [Abstract][Full Text] [Related]
10. Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation. Dang TT; Ziv E; Weinstein S; Meng MV; Wang Z; Coakley FV J Comput Assist Tomogr; 2012; 36(6):669-74. PubMed ID: 23192203 [TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman. LaGrange CA; Lele SM; Strup SE Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124 [TBL] [Abstract][Full Text] [Related]
12. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164 [TBL] [Abstract][Full Text] [Related]
13. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350 [TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis. Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215 [TBL] [Abstract][Full Text] [Related]
15. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536 [TBL] [Abstract][Full Text] [Related]
16. Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma. He J; Gan W; Liu S; Zhou K; Zhang G; Guo H; Zhu B J Comput Assist Tomogr; 2015; 39(5):730-6. PubMed ID: 25955396 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Wei S; Tian F; Xia Q; Huang P; Zhang Y; Xia Z; Wu M; Yang B Cancer Imaging; 2019 Dec; 20(1):1. PubMed ID: 31892340 [TBL] [Abstract][Full Text] [Related]
18. TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma. Xu Y; Rao Q; Xia Q; Shi S; Shi Q; Ma H; Lu Z; Chen H; Zhou X Int J Clin Exp Pathol; 2015; 8(3):2690-9. PubMed ID: 26045774 [TBL] [Abstract][Full Text] [Related]
19. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: findings on MRI and computed tomography imaging. Liu K; Xie P; Peng W; Zhou Z J Magn Reson Imaging; 2014 Aug; 40(2):440-7. PubMed ID: 24136829 [TBL] [Abstract][Full Text] [Related]
20. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]